KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Acquisitions (2020)

Historic Acquisitions for Supernus Pharmaceuticals (SUPN) over the last 1 years, with Q4 2020 value amounting to $1.3 million.

  • Supernus Pharmaceuticals' Acquisitions changed N/A to $1.3 million in Q4 2020 from the same period last year, while for Sep 2022 it was $1.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $950000.0 for FY2021, which is 9968.18% down from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Acquisitions of $1.3 million as of Q4 2020.
  • Supernus Pharmaceuticals' Acquisitions' 5-year high stood at $1.3 million during Q4 2020, with a 5-year trough of $1.3 million in Q4 2020.